Cancer

September 18, 2024

What’s Caterpillar got to do with it?

The role of the private sector in cancer research

By Stephen Doster
September 18, 2024

Turning genes on to turn cancer off

By Leigh MacMillan, Ph.D.
September 18, 2024

The science of large numbers

Cohort studies shed light on cancer

By Stephen Doster
September 18, 2024

The next targeted therapies

By Leigh MacMillan, Ph.D.
September 18, 2024

Symphony of knowledge

Science closes in on cancer

By Bill Snyder
September 18, 2024

Piercing the body with precision

How imaging is aiding the fight against cancer

By Bill Snyder
September 18, 2024

Pathway to glioma?

By Melissa Marino, Ph.D.
September 18, 2024

One arrow’s not enough

By Leigh MacMillan, Ph.D.
September 18, 2024

Lwala diaries – a postscript

By Bill Snyder
September 18, 2024

In the beginning

What developmental biology can teach about cancer
By Melissa Marino, Ph.D.
September 18, 2024

How to crack the cancer code

By Bill Snyder
September 18, 2024

High-tech surveillance

The power of proteomics
By Bill Snyder
September 18, 2024

Hitting the bull’s-eye

Targeted cancer therapies begin making their mark
By Leigh MacMillan, Ph.D.
1 2